joseph physical therapy p.c.

106 atlantic ave unit 19
lynbrook, new york 11563

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 07, 2013

NYS DOS ID#
4357492

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION

Name History
2013 - JOSEPH PHYSICAL THERAPY P.C.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Kahlil Joseph’s New Film Is Steeped in Harlem’s History. And His Own.
    By DANIEL McDERMON - Tuesday Oct 31, 2017

    The director Kahlil Joseph, who has worked with Beyoncé and Kendrick Lamar, presents his most personal work to date at the New Museum.

    Source: NYT > Home Page
  • Bots are becoming highly skilled assistants in physical therapy
    By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017

    Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence.  Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]

    Source: VentureBeat
  • Alibaba Co-Founder Joseph Tsai Said to Buy Brooklyn Nets Stake
    By MICHAEL J. de la MERCED and JOE DRAPE - Friday Oct 27, 2017

    Mr. Tsai has agreed in principle to buy a 49 percent stake in the team, people briefed on the matter said, valuing the franchise at $2.3 billion.

    Source: NYT > Home Page
  • The Rebuilding Years, Post-Sandy
    By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017

    Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed